MarketCap
Facebook
X
TelegramQuarterly report 2023-Q4
added 02-12-2024
Nemaura Medical Operating Income 2011-2026 | NMRD
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Nemaura Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.6 M | -7.57 M | -4.59 M | -4.78 M | -4.48 M | -1.91 M | -1.55 M | -1.54 M | -1.32 M | -586 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -586 K | -9.6 M | -3.79 M |
Quarterly Operating Income Nemaura Medical
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.54 M | -2.05 M | -1.83 M | - | -1.62 M | -1.62 M | -2.44 M | - | -1.79 M | -5.13 M | -3.34 M | - | -1.07 M | -1.07 M | -2.14 M | -911 K | -1.06 M | -1.06 M | -1.12 M | -1.26 M | -933 K | -933 K | -1.15 M | -568 K | -476 K | -448 K | -417 K | -417 K | -375 K | -375 K | -322 K | -494 K | -329 K | -329 K | -390 K | -403 K | -159 K | -784 K | -625 K | - | -340 K | -424 K | -83.9 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -83.9 K | -5.13 M | -1.07 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-7.85 M | $ 32.5 | -8.14 % | $ 1.44 B |  USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 13.77 | 4.86 % | $ 1.97 B | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 269.87 | 0.53 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.53 | -1.12 % | $ 122 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.58 | -1.22 % | $ 394 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 6.36 | 0.32 % | $ 457 M |  Israel |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 39.87 | 0.77 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 75.27 | 1.21 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.52 | - | $ 169 M |  France |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 23.17 | -5.16 % | $ 196 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 46.0 | 1.39 % | $ 1.43 B | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-12.4 M | $ 9.94 | 2.0 % | $ 283 M | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 14.0 | -1.41 % | $ 905 M | Israel |
 |
Establishment Labs Holdings
ESTA
|
-50 M | $ 78.78 | 5.1 % | $ 2.22 B |  Costa-rica |
 |
IRadimed Corporation
IRMD
|
22 M | $ 99.04 | -2.22 % | $ 1.25 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.55 | -0.22 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 92.25 | -1.25 % | $ 12.5 B | USA |
 |
LivaNova PLC
LIVN
|
129 M | $ 69.26 | 1.32 % | $ 3.76 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 1.51 | 2.03 % | $ 59.1 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.88 | - | $ 1.14 M | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 97.06 | -1.57 % | $ 125 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 11.57 | -1.66 % | $ 891 M | USA |
 |
MiMedx Group
MDXG
|
58.9 M | $ 5.35 | 0.28 % | $ 786 M | USA |